title: Arsenic exacerbates atherosclerotic lesion formation and inflammation in ApoE-/- mice.
abstract: Exposure to arsenic-contaminated water has been shown to be associated with cardiovascular disease, especially atherosclerosis. We examined the effect of arsenic exposure on atherosclerotic lesion formation, lesion composition and nature in ApoE-/- mice. Early post-natal exposure (3-week-old mice exposed to 49 ppm arsenic as NaAsO(2) in drinking water for 7 weeks) increased the atherosclerotic lesion formation by 3- to 5-fold in the aortic valve and the aortic arch, without affecting plasma cholesterol. Exposure to arsenic for 13 weeks (3-week-old mice exposed to 1, 4.9 and 49 ppm arsenic as NaAsO(2) in drinking water) increased the lesion formation and macrophage accumulation in a dose-dependent manner. Temporal studies showed that continuous arsenic exposure significantly exacerbated the lesion formation throughout the aortic tree at 16 and 36 weeks of age. Withdrawal of arsenic for 12 weeks after an initial exposure for 21 weeks (to 3-week-old mice) significantly decreased lesion formation as compared with mice continuously exposed to arsenic. Similarly, adult exposure to 49 ppm arsenic for 24 weeks, starting at 12 weeks of age increased lesion formation by 2- to 3.6-fold in the aortic valve, the aortic arch and the abdominal aorta. Lesions of arsenic-exposed mice displayed a 1.8-fold increase in macrophage accumulation whereas smooth muscle cell and T-lymphocyte contents were not changed. Expression of pro-inflammatory chemokine MCP-1 and cytokine IL-6 and markers of oxidative stress, protein-HNE and protein-MDA adducts were markedly increased in lesions of arsenic-exposed mice. Plasma concentrations of MCP-1, IL-6 and MDA were also significantly elevated in arsenic-exposed mice. These data suggest that arsenic exposure increases oxidative stress, inflammation and atherosclerotic lesion formation.
authors.affiliation: Diabetes and Obesity Center and Institute of Molecular Cardiology, University of Louisville, Louisville, KY 40202, USA. sanjay@louisville.edu
authors.forename: Sanjay
authors.initials: S
authors.lastname: Srivastava
authors.forename: Elena N
authors.initials: EN
authors.lastname: Vladykovskaya
authors.forename: Petra
authors.initials: P
authors.lastname: Haberzettl
authors.forename: Srinivas D
authors.initials: SD
authors.lastname: Sithu
authors.forename: Stanley E
authors.initials: SE
authors.lastname: D'Souza
authors.forename: J Christopher
authors.initials: JC
authors.lastname: States
mesh_terms: D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects / Q000378:metabolism; D001021:Aortic Valve / Q000187:drug effects / Q000378:metabolism; D001057:Apolipoproteins E / Q000235:genetics*; D018053:Arsenites / Q000008:administration & dosage / Q000633:toxicity*; D050197:Atherosclerosis / Q000139:chemically induced*; D004305:Dose-Response Relationship, Drug; D007249:Inflammation / Q000139:chemically induced*; D008264:Macrophages / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D032389:Myocytes, Smooth Muscle / Q000187:drug effects / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects*; D017670:Sodium Compounds / Q000008:administration & dosage / Q000633:toxicity*; D013601:T-Lymphocytes / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors
chemical_list: D001057:Apolipoproteins E; D018053:Arsenites; D017670:Sodium Compounds; C017947:sodium arsenite
references.citation: Environ Health Perspect. 2005 Mar;113(3):339-41
references.pmid: 15743725
references.citation: Environ Health Perspect. 2006 Aug;114(8):1293-6
references.pmid: 16882542
references.citation: Mol Cell. 1998 Aug;2(2):275-81
references.pmid: 9734366
references.citation: Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8264-8
references.pmid: 7667279
references.citation: Arterioscler Thromb Vasc Biol. 1999 Jun;19(6):1518-25
references.pmid: 10364084
references.citation: Free Radic Biol Med. 1999 Dec;27(11-12):1405-12
references.pmid: 10641735
references.citation: Circulation. 2002 Apr 16;105(15):1804-9
references.pmid: 11956123
references.citation: Circulation. 1973 Feb;47(2):270-5
references.pmid: 4684927
references.citation: Arch Pathol. 1974 Jun;97(6):360-5
references.pmid: 4825098
references.citation: J Cell Biol. 1985 Mar;100(3):965-73
references.pmid: 3972906
references.citation: Environ Health Perspect. 2001 Oct;109(10):1011-7
references.pmid: 11675266
references.citation: Toxicol Appl Pharmacol. 2008 Feb 15;227(1):1-7
references.pmid: 18022660
references.citation: J Expo Anal Environ Epidemiol. 2003 May;13(3):231-9
references.pmid: 12743617
references.citation: Circulation. 1996 Sep 1;94(5):874-7
references.pmid: 8790019
references.citation: Am J Physiol Heart Circ Physiol. 2002 Dec;283(6):H2612-9
references.pmid: 12388223
references.citation: Circulation. 2004 Jun 1;109(21 Suppl 1):II2-10
references.pmid: 15173056
references.citation: Cardiovasc Res. 2007 Jun 1;74(3):445-55
references.pmid: 17362897
references.citation: J Cell Physiol. 1998 Nov;177(2):324-33
references.pmid: 9766529
references.citation: Epidemiol Rev. 1994;16(2):184-209
references.pmid: 7713176
references.citation: Toxicol Sci. 2009 Feb;107(2):312-23
references.pmid: 19015167
references.citation: Diabetes. 2006 Apr;55(4):901-10
references.pmid: 16567509
references.citation: Science. 2002 Jun 21;296(5576):2145-6
references.pmid: 12077388
references.citation: Atherosclerosis. 2008 Jul;199(1):12-8
references.pmid: 18367191
references.citation: Atherosclerosis. 1999 Mar;143(1):205-11
references.pmid: 10208497
references.citation: Chem Biol Interact. 2008 May 28;173(2):129-40
references.pmid: 18396267
references.citation: J Immunol. 2007 Jul 1;179(1):313-21
references.pmid: 17579051
references.citation: Free Radic Biol Med. 2008 Jul 15;45(2):119-23
references.pmid: 18460347
references.citation: Reprod Toxicol. 2007 Apr-May;23(3):449-56
references.pmid: 17317095
references.citation: Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1255-61
references.pmid: 12775578
references.citation: Atherosclerosis. 1998 Dec;141(2):249-57
references.pmid: 9862173
references.citation: Arterioscler Thromb Vasc Biol. 1996 Apr;16(4):504-10
references.pmid: 8624771
references.citation: Nat Med. 2002 Nov;8(11):1235-42
references.pmid: 12411950
references.citation: Environ Health Perspect. 2003 Nov;111(14):1744-8
references.pmid: 14594625
references.citation: Mol Cells. 2008 May 31;25(3):347-51
references.pmid: 18483467
references.citation: Atherosclerosis. 2003 Oct;170(2):223-8
references.pmid: 14612201
references.citation: Toxicol Appl Pharmacol. 2004 Nov 15;201(1):32-9
references.pmid: 15519606
references.citation: Circulation. 1994 Jul;90(1):42-9
references.pmid: 8026027
references.citation: Cardiovasc Res. 2008 Aug 1;79(3):360-76
references.pmid: 18487233
references.citation: Hypertension. 1995 Jan;25(1):53-60
references.pmid: 7843753
references.citation: Toxicol Appl Pharmacol. 2007 Aug 1;222(3):315-26
references.pmid: 17433393
references.citation: Environ Health Perspect. 2003 Aug;111(11):1429-38
references.pmid: 12928151
references.citation: Science. 2002 Jun 21;296(5576):2143-5
references.pmid: 12077387
references.citation: Atherosclerosis. 1998 May;138(1):147-52
references.pmid: 9678780
references.citation: Science. 2006 Dec 15;314(5806):1687-8
references.pmid: 17170279
references.citation: Circulation. 2004 Jun 15;109(23 Suppl 1):III2-7
references.pmid: 15198959